The 3 analysts offering 12-month price forecasts for Leap Therapeutics Inc have a median target of 3.25, with a high estimate of 8.00 and a low estimate of 2.50. The median estimate represents a +77.60% increase from the last price of 1.83.
The current consensus among 3 polled investment analysts is to Buy stock in Leap Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.31
Reporting Date Mar 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.